Angioplasty or Bypass Surgery: How Cardiologists Decide the Right Treatment

Author: Dr. Kulin Sheth
Medically reviewed by: Dr. Kulin Sheth
Last reviewed: 8 October 2026

Being told that you have blocked heart arteries can lead to an important question: Should I have angioplasty or bypass surgery?

There is no single procedure that is best for every patient.

Coronary angioplasty (PCI) and coronary artery bypass grafting (CABG) are two established ways of restoring blood flow to the heart. The right choice depends on the pattern and complexity of coronary artery disease, symptoms, heart function, diabetes and other medical conditions, procedural and surgical risk, and what is likely to provide the best long-term outcome.

In some patients, neither procedure is immediately necessary and medical treatment and risk-factor control are appropriate.

The decision is therefore not simply about choosing between a stent and surgery. It is about determining which treatment—or combination of treatments—is most appropriate for the individual patient.

What is the difference between angioplasty and bypass surgery?

Angioplasty (PCI)

Coronary angioplasty, or percutaneous coronary intervention (PCI), is a minimally invasive procedure performed through a blood vessel, usually in the wrist.

A catheter is guided to the coronary artery, the narrowed segment is treated with a balloon or another device, and a stent may be implanted to keep the artery open.

Most contemporary coronary stents are drug-eluting stents, which release medication designed to reduce the risk of restenosis.

In selected situations, coronary disease can also be treated without leaving a permanent stent, using a drug-coated balloon or another stentless PCI strategy.

Bypass surgery (CABG)

Coronary artery bypass grafting uses blood vessels taken from elsewhere in the body to create new routes around significant coronary blockages.

The most commonly used arterial conduit is the left internal mammary artery (LIMA), often used to bypass the left anterior descending artery. Vein grafts and other arterial conduits may also be used depending on the patient's anatomy and surgical plan.

CABG is a major operation and generally requires a longer recovery than PCI, but it can offer important advantages in selected patients with complex or extensive coronary disease.

Apollo CVHF provides both coronary angioplasty and cardiothoracic and vascular surgery.

Why isn't one procedure simply better than the other?

PCI has the advantages of being less invasive, generally involving a shorter hospital stay and faster physical recovery.

CABG, on the other hand, can provide more durable revascularisation in certain patterns of complex coronary disease and may offer better long-term outcomes in specific patient groups.

The trade-off is that bypass surgery is a major operation with greater initial surgical burden and a longer recovery.

Therefore, the less invasive procedure is not automatically the better procedure, and the more extensive procedure is not automatically the better one either.

The decision must consider both the immediate risks and the expected long-term benefits.

When is angioplasty usually preferred?

PCI is commonly preferred when the coronary disease is suitable for catheter-based treatment and the expected benefits of opening the artery outweigh the risks.

Examples include:

1. A heart attack requiring urgent reperfusion

For patients with STEMI or other acute coronary syndromes in whom urgent PCI is indicated and can be performed promptly, primary PCI is a cornerstone of emergency treatment.

The objective is to restore blood flow to the blocked coronary artery as quickly as possible and limit myocardial damage.

In an acute heart attack, the immediate treatment decision is different from the decision-making process used for stable, elective coronary disease.

2. Localised coronary disease

A patient with one or a small number of discrete, technically suitable coronary lesions may be an excellent candidate for PCI.

For example, a focal severe narrowing in an otherwise relatively healthy coronary tree may be treated effectively with a stent or, in selected circumstances, a drug-coated balloon.

3. Patients at high surgical risk

Some patients have coronary anatomy that could technically be treated with surgery but have substantial surgical risk because of age, frailty, kidney disease, lung disease or other medical conditions.

In such patients, PCI may be a reasonable alternative when the anatomy is suitable.

The decision is individualised rather than based on age alone.

When is bypass surgery often favoured?

CABG is frequently considered when the coronary disease is extensive, complex or unlikely to be adequately treated with PCI.

This can include:

Significant left main coronary artery disease in appropriate patients
Complex multivessel coronary artery disease
Diffuse or heavily calcified disease that is difficult to treat effectively with stents
Certain patients with diabetes and multivessel coronary disease
Situations where complete revascularisation is difficult to achieve safely with PCI
Selected patients with reduced left ventricular function and suitable coronary anatomy

This does not mean that every patient with diabetes, left-main disease or reduced ejection fraction automatically needs bypass surgery.

The details of the coronary anatomy and the patient's overall clinical profile matter.

For patients with diabetes and multivessel coronary disease, the FREEDOM trial demonstrated lower rates of death and myocardial infarction with CABG than PCI using first-generation drug-eluting stents, although CABG was associated with a higher risk of stroke. Contemporary PCI technology has evolved considerably since that trial, so the results should be interpreted within the broader clinical context rather than used as an automatic rule for every patient with diabetes.

Apollo CVHF provides open-heart bypass surgery as well as minimally invasive bypass surgery for appropriately selected patients.

What does the SYNTAX score have to do with the decision?

The SYNTAX score is an angiographic tool that describes the anatomical complexity of coronary artery disease.

It considers factors such as the number, location and complexity of coronary lesions.

A higher anatomical complexity generally makes PCI more challenging and may favour CABG in appropriate patients, particularly when the disease is extensive.

However, the SYNTAX score is not a standalone treatment decision.

A cardiologist does not simply calculate the score and declare that the patient needs surgery. The score is considered alongside clinical factors, heart function, diabetes, kidney disease, age, frailty, surgical risk and the patient's preferences.

Modern decision-making is more nuanced than “low score equals stent, high score equals bypass.”

What about left main coronary artery disease?

The left main coronary artery supplies a large portion of the heart muscle, so significant left-main disease requires careful assessment.

CABG has an important role in left-main coronary disease, but PCI can also be an appropriate alternative for selected patients, particularly when the anatomy is favourable and the expected outcomes are comparable.

Factors such as the location of the left-main lesion, involvement of the bifurcation, overall coronary complexity and the patient's surgical risk all matter.

In appropriate cases, intravascular imaging such as IVUS can help guide left-main PCI.

The decision is best made through a Heart Team discussion when both PCI and CABG are reasonable options.

Why does diabetes influence the decision?

Diabetes is associated with a higher burden of coronary atherosclerosis and can be associated with diffuse, multivessel and calcified coronary disease.

Patients with diabetes and multivessel coronary disease may therefore derive greater long-term benefit from CABG in selected circumstances.

However, diabetes does not automatically mean bypass surgery.

A patient with diabetes and a single focal coronary lesion may be very appropriately treated with PCI. Conversely, a patient without diabetes may have complex coronary anatomy for which CABG is preferable.

The coronary anatomy and the complete clinical picture remain central to the decision.

Apollo CVHF has a dedicated resource on diabetes and heart disease.

Does reduced heart function favour bypass surgery?

Reduced left ventricular ejection fraction can influence the choice of revascularisation strategy, particularly when significant multivessel coronary disease is present.

In selected patients with ischaemic cardiomyopathy, CABG can improve long-term outcomes.

However, the decision should not be based simply on the presence of a low ejection fraction or the assumption that a “hibernating” heart will necessarily recover after revascularisation.

Assessment may include echocardiography, coronary anatomy and, in selected patients, additional imaging to determine the likely contribution of coronary disease to the impaired heart function.

Apollo CVHF provides advanced echocardiography and a dedicated heart failure service.

Why does complete revascularisation matter?

When several important coronary arteries are diseased, the treatment strategy should aim to address the lesions that are clinically significant and technically appropriate to treat.

PCI can sometimes achieve complete revascularisation, even in complex disease, using advanced techniques.

In other patients, attempting to place multiple stents in long, diffuse or heavily calcified segments may not be the best strategy.

CABG can provide bypass grafts beyond multiple diseased segments and may therefore offer a more comprehensive revascularisation strategy in selected patients.

The important point is that “Can this blockage be stented?” is not the only question.

The more useful question is:

“Which strategy will provide the best overall result for this patient's coronary anatomy and long-term health?”

How do cardiologists know whether a blockage actually needs treatment?

An angiogram shows the shape and severity of a narrowing, but an angiogram alone does not always tell us how much that narrowing is affecting blood flow.

This is particularly important for intermediate coronary lesions.

FFR and iFR

Fractional flow reserve (FFR) and instantaneous wave-free ratio (iFR) are invasive physiological tests used in selected coronary lesions.

They measure pressure across a coronary narrowing and help determine whether the lesion is functionally significant.

If an intermediate narrowing is not causing significant physiological impairment, PCI may provide little benefit, and medical treatment may be preferable.

This helps avoid treating a narrowing simply because it looks severe on an angiogram.

IVUS and OCT

Intravascular ultrasound (IVUS) and optical coherence tomography (OCT) allow the interventional cardiologist to examine the coronary artery from inside.

They can help determine vessel dimensions, assess plaque and calcium, evaluate the result of lesion preparation and optimise stent implantation.

IVUS is particularly valuable in complex PCI and left-main intervention.

Apollo CVHF's interventional programme includes complex coronary angioplasty, rotablation and IVL.

What is the role of CT coronary angiography?

CT coronary angiography (CTCA) provides non-invasive imaging of the coronary arteries.

It is particularly useful in appropriately selected patients with suspected coronary artery disease and can sometimes provide enough information to avoid invasive coronary angiography.

It is not, however, a replacement for invasive angiography in every patient.

Patients with established complex coronary disease being considered for revascularisation often require invasive coronary angiography and, where appropriate, additional physiological or intravascular assessment.

Apollo CVHF provides CT coronary angiography.

What if the coronary arteries are heavily calcified?

Severe coronary calcium can make PCI technically challenging.

A conventional balloon may not adequately expand a heavily calcified lesion, and a stent cannot function properly if it cannot be expanded appropriately.

Specialised plaque-modification techniques can help.

Rotational atherectomy

Rotablation uses a small rotating burr to modify heavily calcified plaque and facilitate balloon expansion and stent delivery.

Intravascular lithotripsy

Intravascular lithotripsy (IVL) uses acoustic pressure waves delivered through a specialised balloon to fracture calcium within the vessel wall.

These techniques are used selectively and are particularly relevant to complex, heavily calcified lesions.

Apollo CVHF provides complex coronary angioplasty with rotablation and IVL.

What is stentless angioplasty?

Not every coronary intervention requires a permanent stent.

Stentless PCI refers to treating a coronary lesion without leaving a permanent metallic scaffold behind. One important approach is drug-coated balloon (DCB) angioplasty.

A drug-coated balloon delivers an anti-proliferative medication to the vessel wall during balloon inflation and is then removed.

Stentless treatment can be useful in selected situations, including some cases of in-stent restenosis and small-vessel disease, and in other lesions where an acceptable result can be achieved without leaving a permanent implant.

It is not appropriate for every coronary blockage.

Apollo CVHF has a dedicated DCB angioplasty and stentless PCI programme.

What is the Heart Team approach?

Some coronary cases do not have an obvious single best treatment.

A patient may have anatomy that favours CABG but also have severe comorbidities that increase surgical risk. Another patient may have technically treatable disease but anatomy that makes complete PCI difficult.

In these situations, a Heart Team approach can be valuable.

The Heart Team brings together relevant specialists—including interventional cardiologists and cardiac surgeons—to review the coronary anatomy, clinical history, procedural options and expected outcomes.

The purpose is not to make every patient undergo a meeting. It is to ensure that when the choice between PCI and CABG is genuinely complex, the patient is not making that decision based on which specialist they happened to see first.

Apollo CVHF describes its multidisciplinary Heart Team approach for complex cardiovascular cases.

Two patients can have similar blockages but require different treatment

Consider two patients with significant disease in three coronary arteries.

Patient A is relatively young, has diabetes and has complex, diffuse multivessel disease. The anatomy is suitable for bypass and the surgical risk is acceptable. CABG may offer a more durable revascularisation strategy.

Patient B has similar coronary anatomy but is very elderly, frail and has severe medical comorbidities that make major surgery substantially more hazardous. PCI may be a reasonable alternative if the coronary anatomy can be treated effectively.

The angiogram provides important information, but the angiogram is not the patient.

The treatment decision incorporates anatomy, physiology, comorbidities, procedural risk, life expectancy, patient preferences and expected long-term benefit.

Angioplasty or bypass after a heart attack

The decision can also change over time.

During an acute STEMI, the immediate priority is to restore blood flow to the blocked culprit artery as quickly as possible, and primary PCI is often the preferred reperfusion strategy when it can be performed promptly.

After the emergency has been treated, further assessment may reveal additional significant coronary disease.

The long-term strategy may then involve staged PCI, CABG or medical treatment depending on the remaining anatomy and the patient's condition.

This is why the treatment plan immediately after a heart attack does not always represent the final revascularisation strategy.

Does bypass surgery cure coronary artery disease?

No.

CABG bypasses existing coronary blockages, but atherosclerosis is a systemic and ongoing disease.

New disease can develop in the native coronary arteries, and bypass grafts can also develop narrowing over time.

Long-term treatment remains essential:

LDL cholesterol should be managed appropriately.
Blood pressure should be controlled.
Diabetes should be treated comprehensively.
Smoking and tobacco should be stopped.
Regular physical activity should be encouraged.
A heart-healthy dietary pattern should be maintained.
Prescribed cardiovascular medicines should be taken consistently.
Follow-up and cardiac rehabilitation should be undertaken when appropriate.

The same principle applies after PCI.

Revascularisation treats the consequences of coronary atherosclerosis; it does not eliminate the underlying disease.

Common questions about angioplasty and bypass

Is angioplasty safer than bypass surgery?

PCI generally involves less immediate surgical trauma and a faster recovery than CABG. However, “safer” depends on what outcome and what time period are being considered.

For some complex coronary anatomies, CABG may provide a better long-term outcome despite having a greater initial procedural burden.

Does every stent require blood thinners?

Patients who receive coronary stents are generally prescribed antiplatelet therapy to reduce the risk of stent thrombosis. The specific drugs and duration depend on the clinical situation and bleeding risk.

Never stop prescribed antiplatelet medication without discussing it with your cardiologist.

Can angioplasty be performed without a stent?

Yes. Selected coronary lesions can be treated using drug-coated balloons or other stentless strategies.

The anatomy must be suitable, and a stent may still be required if the result after balloon treatment is not satisfactory.

Can I have an MRI after receiving a coronary stent?

Modern coronary stents are generally compatible with MRI under specified conditions. Always tell the radiology team that you have a coronary stent and provide your device information if available.

Can bypass surgery be minimally invasive?

Yes. Selected patients may be candidates for minimally invasive bypass procedures, although minimally invasive surgery is not appropriate for every pattern of coronary disease.

Apollo CVHF provides minimally invasive bypass surgery.

Which procedure has the faster recovery?

PCI generally has the shorter recovery because it does not require a chest incision or sternotomy.

CABG requires a longer recovery because it is major surgery. The precise recovery period varies between patients and depends on the surgical technique and overall health.

What should you ask before deciding?

If you have been advised angioplasty or bypass surgery, it is reasonable to ask your cardiologist:

What exactly is the pattern of my coronary disease?
Which arteries are significantly diseased?
Is my disease suitable for PCI?
Would CABG offer a better long-term outcome in my case?
Is the blockage actually responsible for my symptoms?
Would FFR, iFR, IVUS or OCT add useful information?
Is a stent necessary, or could a stentless strategy be appropriate?
What are the risks of PCI and CABG specifically for me?
What happens if I choose medical treatment instead?
Has my case been discussed through a Heart Team if both PCI and CABG are reasonable options?

If you have already been advised to undergo angioplasty or bypass and want another assessment of your coronary anatomy and treatment options, a specialist cardiology second opinion can help clarify the decision.

The right procedure is the one that is right for the patient

Angioplasty and bypass surgery should not be viewed as competing procedures where one is universally superior.

PCI can provide excellent results with a minimally invasive approach and rapid recovery. CABG can provide important advantages in selected patients with complex or extensive coronary disease.

The best treatment depends on the patient, the coronary anatomy, the physiology, the clinical situation and the expected long-term benefit.

For complex cases, a Heart Team can bring these factors together and help determine whether the best approach is medical treatment, angioplasty, stentless PCI, bypass surgery, or a combination of strategies.

At Apollo CVHF, patients with coronary artery disease can be evaluated across interventional cardiology, cardiac imaging and cardiac surgery to determine the most appropriate treatment strategy.

The goal is not simply to open a blocked artery. The goal is to choose the treatment that offers the best balance of safety, symptom relief, durability and long-term cardiovascular benefit for that individual patient.

References

Lawton JS, Tamis-Holland JE, Bangalore S, et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization. Journal of the American College of Cardiology. 2022;79.
Rao SV, O'Donoghue ML, Ruel M, et al. 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes. Journal of the American College of Cardiology. 2025.
Farkouh ME, Domanski M, Sleeper LA, et al. Strategies for Multivessel Revascularization in Patients with Diabetes. New England Journal of Medicine. 2012;367:2375-2384. FREEDOM Trial.
Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS Guidelines on Myocardial Revascularization. European Heart Journal. 2019;40:87-165.
Writing Committee Members. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization. American College of Cardiology/American Heart Association/Society for Cardiovascular Angiography and Interventions.